Nordic pulse oximetry screening - implementation status and proposal for uniform guidelines

Peer reviewe

Pulse oximetry: Evaluation of a potential tool for early detection of critical congenital heart disease

Background: About one third of newborns with life-threatening congenital heart disease leave newborn nurseries without the problem being recognized, and risk death or serious damage from circulatory collapse. The main aim of this thesis has been to evaluate if routine newborn screening with pulse oximetry could improve early in-hospital detection of newborns with duct-dependent circulation (DDC). Papers I, II and IV are methodological studies describing optimal screening cut-offs for pulse oximetry (Paper I), normal range for perfusion index; PPI (Paper II), and deviation of pulse oximetry values from true arterial saturation in cyanosed children (Paper IV). Paper III includes a multicentre screening-study that tests the method prospectively in all newborn nurseries in West Götaland Region (WGR) on 39821 newborns, with blind comparison with neonatal physical examination (NPE), as well as a complete cohort comparison of all newborns with DDC in WGR with all other referring regions (ORR) not screening newborns, and a cost-benefit analysis of screening. Results: Best sensitivity for DDC was achieved with both pre- and postductal saturation cut-off +3% with a New-generation oximeter(NGoxi) on 3 repeated measurements. 29 babies with DDC remained undetected until the discharge examination. NGoxi-screening detected 18/29 (62%) but combining with NPE increased sensitivity to 24/29 (83%). A positive pulse oximetry screening gives a relative risk of 719.8 (95% confidence interval 350.3 to 1479; p 7% of the arterial blood gas saturation occurred in 66.7% (10/15) of CToxi-readings and in 40.0% (6/16) of NGoxi-readings in the below 80% saturation range. Conclusion: Adding NGoxi-screening to neonatal physical examination significantly improved detection of DDC, detected 100% of duct-dependent pulmonary circulation (present in 2 of 5 undiagnosed deaths in ORR), yielded only 0.17% false-positives, and came out cost-neutral